NYSE$VOYA

Voya Financial Inc · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Reported strong first-quarter results driven by growth in Wealth Solutions and Health Solutions, along with effective capital management.

Voya Financial reported a net income of $1,086 million, or $8.29 per diluted share, and adjusted operating earnings of $223 million, or $1.70 per diluted share. The company saw growth in Wealth Solutions and Health Solutions, and continued to execute its capital management strategy, repurchasing $235 million of common stock and $75 million of debt.

  • Net income available to common shareholders was $8.29 per diluted share.
  • Adjusted operating earnings were $1.70 per diluted share, after tax, including $0.66 of prepayment fees and alternative investment income above expectations and $(0.17) of claims due to COVID-19.
  • The company repurchased $235 million of common stock and retired $75 million of debt.
  • Wealth Solutions full service recurring deposits grew 5% and full service net flows were $868 million.

Headline financials

Total Revenue

-$1.96B

Previous: $1.69B-216.1%
EPS (adj)

$1.03

Previous: $1.10-6.4%
Free Cash Flow

$1.1B

Previous: -$84M+1409.5%
Net Income

$1.1B

Previous: -$84M+1409.5%
Operating Income

-$6.21B

Previous: $87M-7237.9%
Gross Profit

-$5.61B

Previous: $727M-871.4%
Cash & Equivalents

$1.17B

Previous: $1.03B+13.3%
Total Assets

$163B

Previous: $156B+4.6%

Revenue & EPS history

Voya · Revenue · Quarterly

-$1.96B

Q1 2021-216.1%vs Q1 2020
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Revenue by segment

Voya · $398M total across 3 segments · Q4 2020

  • Retirement
    $258M+59.3%
  • Investment Management
    $90M+52.5%
  • Employee Benefits
    $50M-9.1%

Forward guidance

Voya expects to repurchase $1 billion of common stock in 2021 and expects Investment Management to achieve its 2-4% net flow organic growth target for 2021 due to a strong, unfunded pipeline.

Tailwinds

  • Strong growth in Wealth Solutions fee revenue
  • Favorable change in deferred acquisition costs and value of business acquired
  • Expected to repurchase $1 billion of common stock in 2021
  • Investment Management expected to achieve a 2-4% net flow organic growth target for 2021
  • Growth across all Health Solutions product lines

Headwinds

  • Net outflows in Investment Management during the quarter
  • Lower earnings in Health Solutions due to higher claims from COVID-19
  • Institutional net outflows of $128 million
  • Retail net outflows of $252 million
  • Higher Group Life loss ratio due to COVID-related claims

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+0.2%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+1.6%

Avg return

30 days after

47%

25 / 53 earnings

Positive

+10.0%

Q4 2022

Best reaction

-9.9%

Q1 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.2%-3.7%+4.2%
Q4 2025-6.5%+1.2%-10.3%
Q3 2025-3.5%-3.5%-3.8%
Q1 2025+9.3%+15.8%+10.7%
Q4 2024+4.8%+5.0%+1.0%
Q3 2024-6.3%+1.6%+2.4%
Q2 2024-1.2%-7.5%-5.6%
Q1 2024+2.2%+2.4%+7.9%
Q4 2023-3.8%-2.3%-4.8%
Q3 2023+2.5%+6.1%+8.2%
Q2 2023-1.8%-2.4%-6.2%
Q1 2023-9.9%-8.2%-10.1%
Q4 2022+10.0%+8.9%+6.4%
Q3 2022-2.2%-2.0%-4.0%
Q2 2022+2.9%+1.8%+3.2%
Q1 2022+6.4%+0.8%+7.1%
Q4 2021+2.3%+1.0%-10.1%
Q3 2021-2.4%-2.8%-9.5%
Q2 2021+3.5%+4.2%-1.3%
Q1 2021-4.3%-1.9%-8.1%
Q4 2020-4.3%-5.8%+9.4%
Q3 2020+1.6%+6.8%+18.8%
Q2 2020+0.2%+4.2%+2.6%
Q1 2020-5.3%+1.7%+12.9%
Q4 2019-0.6%+0.4%-26.5%
Q3 2019+3.6%+3.3%+3.0%
Q2 2019-4.4%-5.9%-2.8%
Q1 2019-1.4%-0.9%+0.0%
Q4 2018+4.1%+1.8%+4.8%
Q3 2018+5.8%+6.9%+8.0%
Q2 2018-1.0%-0.5%-0.9%
Q1 2018-0.7%-0.7%-0.8%
Q4 2017+6.5%+5.3%+12.5%
Q3 2017+2.4%+3.8%+9.6%
Q2 2017+3.4%+4.2%-2.6%
Q1 2017-4.1%-3.8%-7.1%
Q4 2016-2.7%+0.0%-1.1%
Q3 2016-1.0%+2.0%+28.9%
Q2 2016+8.5%+11.5%+15.5%
Q1 2016-7.6%
Q4 2015-2.8%
Q3 2015-1.6%
Q2 2015-2.6%
Q1 2015+2.9%
Q4 2014+3.6%
Q3 2014+0.6%
Q2 2014-2.8%
Q1 2014-2.1%
Q4 2013+2.5%
Q3 2012+4.7%
Q3 2013+6.4%
Q2 2013-1.0%
Q1 2013+1.4%
Q2 2012
Q1 2012
Q4 2011
Q3 2011

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro